ARCHIVES

Olaparib, A PARP Inhibitor, Can Reduce Tumor Size In Advanced Ovarian Cancer

This article is from The Cancer Letter archive.

Vol. 33 No. 8 | August 27, 2010

Download PDF Visit The Full Archive

Related Articles

NIH To Give 3 Percent Increase to Grants

March 20, 2009

Bladder Cancer Epidemiological Study Involves 3,000 Patients

March 2, 1979

In Congress: Senate Committee Provides Increase To DOD Program

August 1, 1997

Bishop: Scientists Need Seat At NCI Executive Committee, More Voice In Decision Making

February 24, 1995

Dendreon Claims “Clear Hit” On Provenge, But Skeptics Await Data Presentation

April 17, 2009

Clinical Trials: Stories On Results Can Have Unintended Consequences

May 15, 1998